Skip to main content
Clinical Trials/EUCTR2006-003194-27-BE
EUCTR2006-003194-27-BEActive, not recruitingPhase 1

mirtazapine versus placebo in functional dyspepsia: a randomized, double-blind, placebo-controlled trial - mirtazapine versus placebo in functional dyspepsia

niversity Hospitals KU Leuven0 sites60 target enrollmentStarted: August 1, 2006Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting
Sponsor
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • functional dyspepsia diagnosed according to international consensus criteria (Rome II criteria)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • 1. organic gastro-intestinal disorders (for example oesophagitis, peptic ulcer, gastritis)
  • 2. current psychiatric disorders (mood & anxiety disorders, eating disorders, psychosis)
  • 3. intake of prokinetic and/or spasmolytic drugs (PPI allowed)
  • 4. intake of antidepressants (SSRI, TCA) and/or neuroleptics during the past two months
  • 5. intake of analgetics (paracetamol allowed)
  • 6. history of major abdominal surgery
  • 7. pregnancy or lactation
  • 8. recent exposure to significant radiation

Investigators

Sponsor
niversity Hospitals KU Leuven

Similar Trials